Mirai Medical, a Galway based cancer treatment start-up, is leading a consortium planning to invest €7.2 million in developing a better way to treat gastrointestinal cancer, as well as potentially treating all solid tumours. The company, founded by Dr Declan Soden, is leading a group that also includes Nasdaq listed Advanced Energy and three Irish universities – NUIG, UCC and Trinity in Dublin. About €4.78 million of the funding being invested in researching these new treatments was awarded last week under the state’s Disruptive Technology Innovation Fund (DTIF). This award will allow Mirai Medical to expand its ePORE platform a…

Join The Currency

Sign up today: Full annual membership for just €200.

Don’t miss out on what is going on with our daily unique stories from our team of skilled journalists and insightful commentators.

Members of The Currency get full access to over 2,500 exclusive interviews, investigations, and analysis, plus over 180 podcasts.

Annual membership is just €200 for the first year, a saving of €100.

Or try The Currency for the first month for a special introductory rate of €5, a saving of €20.

Cancel at any time.

To become a member today click here.